chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 34.0
Sex: U
Vaccine: COVID19
Symptoms: Pruritus
Clinical narrative: I started to get itchy little bumps on bottom of my arm; This is a spontaneous report from a contactable consumer or other non hcp (patient). A 34-year-old patient of an unspecified gender received second dose of bnt162b2 (BNT162B2 PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, Batch/Lot number: UNKNOWN), via an unspecified route of administration on an unspecified date (at the age of 34-years-old) as dose 2, single for covid-19 immunisation. The medical history of the patient was reported as none. The concomitant medications of the patient were not reported. The patient previously received first dose of BNT162B2 (solution for injection) on an unspecified date as a single dose for COVID-19 immunisation. The patient experienced I started to get itchy little bumps on bottom of my arm on an unspecified date. the outcome if the events was reported as unknown.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Somnolence, Vaccination site pain, Vaccination site pruritus
Clinical narrative: She added 2 days later, on Sunday, it was then itching like a "bee sting" then it continued to itch, and it now feels like a "mosquito bite".; Sleepy, Groggy, Slept for 12 hours; injection "site/arm was a little tender"; it was painful when she reached out to get something/ Right Arm Hurting, Sore and Tender; This is a spontaneous report from a contactable consumer (patient).   A 70-year-old female patient received second dose of BNT162B2 (Pfizer-BioNTech Covid-19 Vaccine, solution for injection, Lot number: EW0176), on 29Apr2021 at 14:00 (at the age of 70-year-old) via an unspecified route of administration, for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. Family medical history relevant to AE was none. The patient previously received historical vaccine included first dose of BNT162B2 (Pfizer-BioNTech Covid-19 Vaccine, solution for injection, lot number: EW0158 and expiration dates was not reported), via an unspecified route of administration, for COVID-19 immunisation and her arm was a little sore. On 29Apr2021 at 17:00, her right arm hurting, sore and tender, she felt sleepy, groggy, slept for 12 hours and on 02May2021, her right arm itching, like a mosquito bite and was a bee sting at first at injection site. the caller stated that she received her final shot on Thursday 29Ar2021. caller stated after the first one, her arm was a little sore. Caller stated this time, her arm in the site where she got the vaccine was tender and painful, so she stopped reaching up to do exercises. She added 2 days later, on Sunday, it was then itching like a 'bee sting' then it continued to itch, and it now feels like a 'mosquito bite'. She stated that the paper said to put a cold wet towel on the site, so she did that. The itchiness persisted. She asked if her symptoms were normal after getting the vaccine. Caller stated that she slept for 12 hours and when she woke up and she was still sleepy until another 8-9 hours, but she couldn't sleep longer, she had to go to the store, states it was a groggy sleepy. She further clarified that she went to reach up to get something and the arm pain worsened so she didn't want to cause any more pain, so didn't reach up. She asked what to do to alleviate her symptom from the Pfizer-BioNTech COVID-19 vaccine. The seriousness was unspecified for the events. On 30Apr2021, the outcome of the events sleepy was recovered, while outcome of the rest all events was not recovered.   No follow-up attempts are needed. No further information is expected.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Herpes zoster
Clinical narrative: I got the Shingles 9-10 days after the first Pfizer Vaccine on 17Mar2021. I felt the first bumps late night on 26Mar2021; This is a spontaneous report from a contactable consumer. A 51-years-old female patient received bnt162b2 (Formulation: Solution for injection; Solution for injection; Batch/Lot Number: EP7534), dose 1 via an unspecified route of administration, administered in Arm Left on 17Mar2021 15:00 PM as DOSE 1, SINGLE for covid-19 immunisation. Medical history included fibromyalgia and uterine cancer from an unknown date and unknown if ongoing. Concomitant medications included duloxetine hydrochloride (CYMBALTA) and gabapentin (GABAPENTIN) taken for an unspecified indication, start and stop date were not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 26Mar2021 23:00 PM patient experienced shingles I got the Shingles 9-10 days after the first Pfizer Vaccine on 17Mar2021. I felt the first bumps late night on 26Mar2021. Diagnosed 29Mar2021. ae resulted in doctor or other healthcare professional office/clinic visit. The patient received treatment with Higher doses of Gabapentin. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The outcome of the events was recovered.   No follow-up attempts are possible. No further information is expected.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Herpes zoster
Clinical narrative: Diagnosed with shingles less than 2 weeks after receiving second vaccine; This is a spontaneous report from a non-contactable consumer (patient). A 41-year-old female non-pregnant patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Batch/Lot number: EW0151, Expiration date: not reported), via an unspecified route of administration in arm right on 15Apr2021 at 10:45 AM (at the age of 41-year-old) as a dose 2, single for COVID-19 immunization. The patient's medical history included known allergy to penicillin. The patient's concomitant medications were not reported. Historical vaccine included BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Batch/Lot number: ER0727, Expiration date: not reported), via an unspecified route of administration on 25Mar2021 at 10:15 AM (at the age of 41-year-old) as a dose 1, single for COVID-19 immunization. It was reported that, the patient was not pregnant at time of vaccination. Other vaccine in four weeks was reported as no. No Covid prior vaccination and no Covid tested post vaccination. The patient received other vaccine same date vaccine date was on 15Apr2021. On 20Apr2021, the patient was diagnosed with shingles less than 2 weeks after receiving second vaccine. This resulted in doctor or other healthcare professional office/clinic visit. Treatment was received for the event and treatment medications included anti-viral medication and cortisone cream. The outcome of the event was not recovered. No follow up attempts are possible. No further information is expected.
Age: 17.0
Sex: M
Vaccine: COVID19
Symptoms: Pharyngitis streptococcal
Clinical narrative: Strep throat; This is a spontaneous report received from a Pfizer Program. A contactable consumer or other non hcp (parent) reported. A 17-years-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection, lot number and expiration date were not reported), via an unspecified route of administration on 15Apr2021 (Age at vaccination was 17 years) as dose 1, single for covid-19 immunization. The patient medical history was not reported. There were no concomitant medications. On unspecified date in 2021 the reporter said that her children received the 1st dose of the vaccine and they are scheduled to get the 2nd dose on 05May2021, however, they developed strep throat. She would like to know if they can still go and get the 2nd dose as scheduled. The outcome of event was unknown.  No follow-up attempts are possible; information about lot/batch number cannot been obtained
Sex: F
Vaccine: COVID19
Symptoms: Herpes zoster, Pain, Pruritus, Rash
Clinical narrative: rash on thigh; felt like shingles; painful; itchy; This is a spontaneous report from a contactable consumer or other non hcp (patient). A 63-years-old non-pregnant female patient received BNT162B2 (BNT162B2) via an unspecified route of administration on Apr2021 (Batch/Lot number was not reported) as dose 1, single for covid-19 immunization. The patient medical history was not reported. Concomitant medications included unspecified vaccine on Apr2021 (other vaccine same date vaccine date Apr2021). facility type vaccine was reported as Pharmacy or Drug Store. Patient had no covid prior vaccination. It was reported that on an unspecified date, 2 weeks after first dose of vaccine the patient developed rash on thigh which looked and felt like shingles. dot worse for two weeks spreading in the area. Painful and itchy. started to resolve after 3 weeks. The adverse events resulted in doctor or other healthcare professional office/clinic visit. Patient has not received any treatment for the events. Patient was tested for covid post vaccination. The patient underwent lab tests and procedures which included nasal swab, covid test (sars-cov-2 test) which result was negative on 06Apr2021. The patient was not recovered from the events at the time of report.  The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Varicella
Clinical narrative: varicella; This is a spontaneous report from a contactable Pharmacist. A 55-years-old female patient received first dose of bnt162b2 (Pfizer-BioNTech Covid-19 Vaccine, Solution injection; Batch/Lot number was not reported), via an unspecified route of administration on 14Apr2021 as single dose for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient experienced varicella as diagnosed by her physician and was treated with cream from 16Apr2021 to 23Apr2021. Caller wanted to confirm if Patient can get vaccinated for the second dose. The outcome of the event was unknown.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 28.0
Sex: M
Vaccine: COVID19
Symptoms: Blister, Herpes zoster, Rash
Clinical narrative: I had shingles; The blisters have yet to pop or crust with more rash beginning along L2 8 days after the initial outbreak; The blisters have yet to pop or crust with more rash beginning along L2 8 days after the initial outbreak; This is a spontaneous report from a contactable consumer or other non hcp. A 28-years-old male patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Batch/lot number: ER8731) via an unspecified route of administration in Arm Left on 27Apr2021 12:00 (age at vaccination 28years old) as single dose for covid-19 immunisation. Medical history included attention deficit hyperactivity disorder from an unknown date and un-known if ongoing Other medical history: Adult ADHD. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Concomitant medication(s) included lisdexamfetamine mesilate (VYVANSE) taken for an unspecified indication, start and stop date were not reported. Since the vaccination, the patient had not been tested positive for COVID-19. The patient previously took bactrum t and experienced drug hypersensitivity, minocycline and experienced drug hypersensitivity, formaldehyde and experienced drug hypersensitivity. The patient had historical vaccine of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Batch/lot number: ER8737) via an unspecified route of administration in Arm Left on 06Apr2021 at 02:00 (age at vaccination 28years old) as single dose for covid-19 immunisation and patient rash with first dose. On unspecified date in 2021 the patient experienced i had shingles, the blisters have yet to pop or crust with more rash beginning along l2 8 days after the initial outbreak. The patient did not receive any treatment for the adverse events. The clinical outcome of the event was not recovered.  No follow-up attempts are needed. No further information is expected.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Herpes zoster, Musculoskeletal stiffness, Myalgia, Neuralgia
Clinical narrative: Second dose increased stiffness in left leg, mostly left calf; all over muscle soreness; then by day 3 puffy left leg plus neuralgia at site of past shingles left shoulder blade; then by day 3 puffy left leg plus neuralgia at site of past shingles left shoulder blade; This is a spontaneous report from a contactable consumer (patient) reported for herself that. A 74-years-old female patient  received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection), dose 2 via an unspecified route of administration, administered in Arm Left on an unspecified date (Batch/Lot Number: EW0158, EW0175) as DOSE 2 SINGLE for covid-19 immunization(Age at vaccination 74 years). The patient past Medical history included blood pressure measurement from an unknown date and unknown if ongoing, asthma from an unknown date and unknown if ongoing and known allergies codeine. The patient's concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccine within 4 weeks prior to covid-19 vaccination. The patient has not received other medications in two weeks. On an unspecified date after the administration of second dose of vaccine the patient experienced increased stiffness in left leg, mostly left calf, all over muscle soreness, then by day 3 puffy left leg plus neuralgia at site of past shingles left shoulder blade, and general adverse reaction perhaps related to shingles sensitivity when experiencing immune storm. The event outcome was Not recovered.  No follow-up attempts needed. No further information is expected.
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Herpes zoster, Inappropriate schedule of product administration
Clinical narrative: inappriate schedule of vaccine administration; The day after my second dose of was administered was when I noticed the shingles on my chin; This is a spontaneous report from a contactable consumer (Patient). A 32-year-old non pregnant female patient received second dose of bnt162b2 (PFIZER BIONTECH COVID-19 mRNA VACCINE; Solution for injection; Lot Number: EN6206), via an unspecified route of administration on 19Feb2021 (at the age of 31-year-old) administered in Arm Left as a single dose for COVID-19 Immunization at School or Student Health Clinic. The patient had received first dose of bnt162b2 (PFIZER BIONTECH COVID-19 mRNA VACCINE; Solution for injection; Lot Number: EN6206), via an unspecified route of administration on 19Feb2021 at 21:15 pm administered in Arm Left as a single dose for COVID-19 Immunization at School or Student Health Clinic. The patient medical history and concomitant medications were not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. The patient had no allergies. On 13Mar2021 at 07:00 AM, the day after my second dose of was administered was when I noticed the shingles on my chin. From there is progressed into full blown shingles. Therapeutic measures were taken as a result of the event and treatment included Valtrax.The outcome of the event was recovered for shingles and unknown for another event.
Age: 53.0
Sex: M
Vaccine: COVID19
Symptoms: Diarrhoea, Gastrointestinal disorder, Headache, Pain, Pain in extremity
Clinical narrative: He was achy all over after the first shot when mentioning the arm pain; Gastro issues; I've had close to diarrhea for about 2 weeks now, since the first dose; Headache; Pain at the injections site, pain in his arm; Pain at the injections site, pain in his arm; This is a spontaneous case received from a contactable consumer (patient). A 53-year-old male patient received first dose of bnt162b2 (BNT162B2, PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot number: EW0158), via intramuscular route in left deltoid on 07Apr2021 (age at vaccination 53-year-old) as DOSE 1, SINGLE for COVID-19 immunisation. The patient's medical history included overweight and afraid of this possible side effects affecting him even more than COVID-19 infection. Concomitant medications were not reported. On an unspecified date, the patient stated that he had close to diarrhoea for about 2 weeks now, since the first dose. On 07Apr2021, the patient experienced pain at the injection site, pain in the arm that started right away after getting the 1st shot. He could not put weight on the arm or without feeling a little pain. The patient stated that he was achy all over after the first shot when mentioning the arm pain. On 12Apr2021, the patient stated that he experienced the worst headache of his life/ When he got the 1st shot, the Monday after, he experienced the worst headache of his life worse than any hang over/ After the first COVID vaccine he experienced the worst headache of his life: It was so bad it knocked him to knees he took Tylenol and it went away. On an unknown date patient stated that he had gastro issues and stated that he had stool that was not fully formed, not diarrhea and not normal but, runny. It was not formed. He is feeling like he has to go after the second shot on 28Apr2021. It has not subsided yet, it was still kind of going right now. He is not rushing to the bathroom every 5 minutes, but its not comfortable, so its improved since the first time, he was very crampy and his stool was liquidy and now it is more solid, it is slightly improving. The outcome of the event pain, diarrhoea and pain in extremity was unknown. The outcome of the event headache was recovered on 12Apr2021 and for other events outcome was recovering.  No follow-up attempts are needed. No further information was expected..
Age: 53.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: He was achy all over after the first shot when mentioning the arm pain; Gastro issues; I've had close to diarrhea for about 2 weeks now, since the first dose; Headache; Pain at the injections site, pain in his arm; Pain at the injections site, pain in his arm; This is a spontaneous case received from a contactable consumer (patient). A 53-year-old male patient received first dose of bnt162b2 (BNT162B2, PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot number: EW0158), via intramuscular route in left deltoid on 07Apr2021 (age at vaccination 53-year-old) as DOSE 1, SINGLE for COVID-19 immunisation. The patient's medical history included overweight and afraid of this possible side effects affecting him even more than COVID-19 infection. Concomitant medications were not reported. On an unspecified date, the patient stated that he had close to diarrhoea for about 2 weeks now, since the first dose. On 07Apr2021, the patient experienced pain at the injection site, pain in the arm that started right away after getting the 1st shot. He could not put weight on the arm or without feeling a little pain. The patient stated that he was achy all over after the first shot when mentioning the arm pain. On 12Apr2021, the patient stated that he experienced the worst headache of his life/ When he got the 1st shot, the Monday after, he experienced the worst headache of his life worse than any hang over/ After the first COVID vaccine he experienced the worst headache of his life: It was so bad it knocked him to knees he took Tylenol and it went away. On an unknown date patient stated that he had gastro issues and stated that he had stool that was not fully formed, not diarrhea and not normal but, runny. It was not formed. He is feeling like he has to go after the second shot on 28Apr2021. It has not subsided yet, it was still kind of going right now. He is not rushing to the bathroom every 5 minutes, but its not comfortable, so its improved since the first time, he was very crampy and his stool was liquidy and now it is more solid, it is slightly improving. The outcome of the event pain, diarrhoea and pain in extremity was unknown. The outcome of the event headache was recovered on 12Apr2021 and for other events outcome was recovering.  No follow-up attempts are needed. No further information was expected..
Age: 22.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Hypersensitivity, Vomiting
Clinical narrative: vomiting; diarrhea; seems like allergy; This is a spontaneous report from a non-contactable consumer or other non hcp (patient). A 22-years-old non-pregnant female patient received BNT162B2 (Pfizer-Biontech Covid-19 Vaccine, Formulation: solution for injection, Batch/Lot Number unspecified, expiration date unspecified), via an unspecified route of administration on 08Apr2021 as DOSE 2, SINGLE for covid immunization (22 year when vaccinated) public health clinic. Previously the patient received BNT162B2 (Pfizer-Biontech Covid-19 Vaccine, Formulation: solution for injection, Batch/Lot Number unspecified, expiration date unspecified), via an unspecified route of administration on 18Mar2021 as DOSE 1, SINGLE for covid immunization (22 year when vaccinated). The patient did not take any other medication within 4weeks of vaccination. The patient medical history and concomitant medications were not reported. The patient was not diagnosed with COVID-19 prior to the vaccination. On 13Apr2021 07:00, almost after 4weeks of vaccination the patient experienced vomiting, diarrhoea and seems like allergy. The patient did not receive any treatment for the events. The patient had to visit doctor/emergency room due to the events. The outcome of the events was reported as not recovered.   No follow-up attempts are possible. Information about lot/batch number cannot be obtained.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Herpes zoster
Clinical narrative: Family friend believes Pfizer vaccine caused shingles; This is a spontaneous report from a contactable consumer or other non hcp. A 55-years-old non-pregnant female patient received bnt162b2 (BNT162B2) formulation solution for injection, (Lot number and expiry date was not reported) via an unspecified route of administration on an unspecified date in Apr2021 (at the age of 55-years-old) as a single dose for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient did not receive any other vaccines within four weeks prior to the vaccination. Other medications in two weeks: not known. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 02May2021 the patient experienced family friend believes pfizer vaccine caused shingles. Therapeutic measures were taken as a result of family friend believes pfizer vaccine caused shingles. Outcome of the events was not recovered.   No follow-up attempts are possible, information about lot/batch number cannot be obtained. No further information is expected.
Age: 48.0
Sex: U
Vaccine: COVID19
Symptoms: Herpes zoster
Clinical narrative: I got shingles; This is a spontaneous report from a contactable consumer or other non-Health Care Professional. A 48-years-old patient of an unspecified gender received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number : ER8729 and Expiry date: Unknown), dose 2 via an unspecified route of administration, administered in Arm Left on 07Apr2021 15:00 as DOSE 2, SINGLE for covid-19 immunization. Medical history included , hypersensitivity from an unknown date and unknown if ongoing Known allergies: Eritromicyn.The patient's concomitant medications were not reported. The patient did not receive any other vaccines within 4 weeks prior to the Covid vaccine. The patient received other medications two weeks of vaccination. The patient previously took bnt162b2 for covid-19 immunization, eritromicin. On 07May2021 18:00 The patient experienced i got shingle.Therapeutic measures were taken as a result of i got shingles. The outcome of event was recovering.  No further information is expected.
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: Herpes zoster
Clinical narrative: Shingles after on and a half weeks of 1st shot; This is a spontaneous report from a contactable consumer (patient). A 64-years-old male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot Number: Unknown), via an unspecified route on 17Apr2021 at 16:00 (at the age of 64-years) as dose 1, single in the left arm for covid-19 immunisation. The patient medical history known allergies to only latex gloves with powder. The patient concomitant medications were not reported. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any other medications in two weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 28Apr2021 at 10:00, the patient experienced shingles after on and a half weeks of 1st shot. Patient visited to doctor or other healthcare professional office/clinic visit. Patient received treatment for event with Acyclovir 800 mg 1tablet 5x/day for 7days. The outcome of the event was recovering.  No follow-up attempts are possible, information about lot/batch number cannot be obtained. No further information is expected.
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Feeding disorder, Influenza like illness, Lethargy, Nausea
Clinical narrative: nausea; severe Vomiting; continued severe lethargy; general flu-like symptoms (fever,chills, shaking, unable to eat); fever; chills; shaking; unable to eat; This is a spontaneous report from a contactable consumer (patient). A 44-year-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number and expiration date: not reported), via an unspecified route of administration, administered in Left arm on 04May2021 10:00 at the age of 44-years-old as dose 2, single for covid-19 immunisation. The patient's medical history was not reported. There were no concomitant medications. The patient historical vaccine includes first dose, BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number and expiration date: Not reported), via an unspecified route of administration, administered in Left arm on 13Apr2021 at the age of 44-years-old as single dose for covid-19 immunisation. The patient previously took amoxicillin family of medications and experienced allergy. The patient did not receive other vaccine in four weeks of vaccination. The patient did not receive other medications in two weeks of vaccination. The patient was not diagnosed with COVID-19 prior vaccination. The patient has not been tested for COVID-19 post vaccination. On 04May2021 at 22:30, the patient experienced Nausea followed by severe Vomiting (40-50 times in several hours) which began about 12 hours after the vaccine and lasted around 5 hours and continued severe lethargy and general flu-like symptoms (fever, chills, shaking, unable to eat). No treatment was received for adverse events. The outcome of the events was recovering.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Tremor, Vomiting
Clinical narrative: nausea; severe Vomiting; continued severe lethargy; general flu-like symptoms (fever,chills, shaking, unable to eat); fever; chills; shaking; unable to eat; This is a spontaneous report from a contactable consumer (patient). A 44-year-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number and expiration date: not reported), via an unspecified route of administration, administered in Left arm on 04May2021 10:00 at the age of 44-years-old as dose 2, single for covid-19 immunisation. The patient's medical history was not reported. There were no concomitant medications. The patient historical vaccine includes first dose, BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number and expiration date: Not reported), via an unspecified route of administration, administered in Left arm on 13Apr2021 at the age of 44-years-old as single dose for covid-19 immunisation. The patient previously took amoxicillin family of medications and experienced allergy. The patient did not receive other vaccine in four weeks of vaccination. The patient did not receive other medications in two weeks of vaccination. The patient was not diagnosed with COVID-19 prior vaccination. The patient has not been tested for COVID-19 post vaccination. On 04May2021 at 22:30, the patient experienced Nausea followed by severe Vomiting (40-50 times in several hours) which began about 12 hours after the vaccine and lasted around 5 hours and continued severe lethargy and general flu-like symptoms (fever, chills, shaking, unable to eat). No treatment was received for adverse events. The outcome of the events was recovering.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Sex: F
Vaccine: COVID19
Symptoms: Herpes zoster
Clinical narrative: Shingles; This is a spontaneous report from a contactable consumer (patient). A 58-year-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot Number: EL1283), dose 2 via an unspecified route of administration on an unspecified date in 2021 as dose 2, single for COVID-19 immunization. Medical history was none reported. The patient's concomitant medications were not reported (Other medications in two weeks). The patient was not pregnant at the time of vaccination. The patient previously received first dose of BNT162B2 (Lot number: EK9231), administered on Left arm on 11Jan2021 for COVID-19 immunization, received sulfur and experienced known allergies. Facility where COVID-19 vaccine was administered at Hospital. The patient did not receive any other vaccine in 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Post vaccination, the patient had not been tested for COVID-19. On 06May2021 20:00, patient experienced shingles. Patient visited doctor or other healthcare professional office/clinic visit for adverse event. Therapeutic measures (Antiviral) were taken as a result of shingles (herpes zoster). The clinical outcome of event was not recovered.  No follow-up attempts are possible. No further information is expected.
Age: 87.0
Sex: U
Vaccine: COVID19
Symptoms: Feeling abnormal, Herpes zoster
Clinical narrative: I have that feeling that I have the shingles; Shingles; This is a spontaneous report from a contactable Consumer or other non-HCP (patient). An 87-year-old patient of an unspecified gender received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Lot Number: ES7229), dose 2 via an unspecified route of administration on 02May2021 (Sunday) (at the age of 87-year-old), as DOSE 2, SINGLE for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient previously received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Lot Number: EP7533), via an unspecified route of administration on 11Apr2021, as single for covid-19 immunisation. On an unspecified date in 2021, the patient experienced shingles like the nerve reactions that I have it on my face. The clinical details of the events as follows: Consumer stated, What I am calling about was I am having the same, I had that feeling that I have the shingles, is that a reaction or am I really getting the shingles. I did not know, I have had the shingles before about 4-5 years ago, but the shingles, this is like the nerve reactions that I have it on my face as I had it before and was this you take a tip thing or should I get a shingles shot. Consumer stated, do I need to get to the pharmacy for shingles shot. Consumer stated, I have not had any problems with either shots, so I did not know just the shingles coming back after 4-5 years or what. Consumer stated, I had shingles, I had no effect from either shot (Unspecified Shot). I have had shingles before long time ago and so I was wondering about. They were not very good because (incomplete sentence). The patient outcome of the events was Unknown at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 34.0
Sex: M
Vaccine: COVID19
Symptoms: Herpes zoster, Rash, Rash erythematous
Clinical narrative: I have a rash on my right thigh/also have a red rash on my back that appears to be shingles; I have a rash on my right thigh/also have a red rash on my back that appears to be shingles; I have a rash on my right thigh/also have a red rash on my back that appears to be shingles; This is a spontaneous report from a contactable consumer (patient). A 34-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot number was not reported) via an unspecified route of administration, administered in Arm Left on 22Apr2021 15:30 (at the age of 34 years old) as dose 1, single for COVID-19 immunisation. Medical history included colitis ulcerative from an unknown date and unknown if ongoing. Concomitant medication within two weeks included mesalazine (LIALDA) taken for an unspecified indication, start and stop date were not reported. Patient did not received other vaccine within four weeks of COVID vaccine. Patient did not have COVID prior to vaccination. The patient experienced as, "i have a rash on my right thigh/also have a red rash on my back that appears to be shingles" on 04May2021. Event reported as, patient have a rash on his right thigh that was otherwise unexplained. Patient also have a red rash on his back that appears to be shingles. No treatment were given for the events. Outcome of all the events were resolving.  The lot number for [BNT162B2], was not provided and will be requested during follow up.
Age: 45.0
Sex: M
Vaccine: COVID19
Symptoms: Herpes zoster, Hypoaesthesia, Paraesthesia
Clinical narrative: shingling; tingling and numbness in the arm; tingling and numbness in the arm; This is a spontaneous report from consumer or other non-health professional via a Regulatory Authority, reporting for himself.  A 46-years-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch no: not reported/Lot number: EW0173, Expiry date: unknown) via an unspecified route of administration, administered in left arm on 04May2021 14:40 (at the age of 45-years-old) as dose 2, single for COVID-19 immunization at Health Care Professional or Clinic site. Patient medical history and concomitant medications were not reported. Historical vaccine included bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch no: not reported/Lot number: EW0158; Expiry date: unknown) via an unspecified route of administration, administered in left arm on 08Apr2021 at 13:45 (at the age of 45-years-old) for COVID-19 immunization at College. No additional Vaccines Administered on Same Date of the Pfizer Suspect. No Prior Vaccinations were taken within 4 weeks of vaccination. No AE reported following prior vaccinations. No Family Medical History reported to Relevant to AEs. The patient reported that he received both doses of the Pfizer Covid 19 vaccine. After second dose of Pfizer Covid 19 Vaccine, on 08May2021 patient experienced with tingling and numbness in the arm an adverse reaction and on an unknown date experienced with shingling. Patient wanted to know are these known side effects for vaccine. AEs does not require to visit Emergency room or Physician office. Investigation Assessment was reported as No. Relevant Tests reported as none. The outcome of the events tingling and numbness in the arm was not recovered and shingles was unknown.  No follow-up attempts are needed. No further information is expected.
Age: 41.0
Sex: M
Vaccine: COVID19
Symptoms: Herpes zoster
Clinical narrative: Shingles - c2 Dermatone; This is a spontaneous report received from a contactable consumer or other non-health care professional. A 42-year-old male patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot Number: Unknown), via an unspecified route of administration, administered in Arm Left on 19Apr2021 12:30 (at the age of 41-years-old) as dose 2, single for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, was the patient did not diagnosed with COVID-19. Since the vaccination, did not patient been tested for COVID-19. The patient did not receive other medications in two weeks of vaccination. Patient received vaccine Facility in other. The patient previously took first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot Number: Unknown) via an unknown route of administration, administered in Arm left on 22Mar2021 (at the age of 41-years-old) as dose 1, single for COVID-19 immunisation. The patient experienced shingles - c2 dermatone on 05May2021 06. Treatment was received for the events as bacterial ointment. Patient visited Doctor or other healthcare professional office/clinic visit. The outcome of the event was reported as recovering.
Sex: M
Vaccine: COVID19
Symptoms: Coagulopathy
Clinical narrative: He is worried because he has heard about issues with blood clots with the vaccine.; This is a spontaneous report from a contactable consumer. A 66-years-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for Injection, Batch/Lot number: Unknown) via an unspecified route of administration on an unspecified date as DOSE 1, SINGLE for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. Patient received the first dose of the Pfizer Covid 19 vaccine three weeks ago tomorrow. Patient supposed to get the second dose tomorrow. Patient had an accident yesterday and pinched his right middle finger. Patient usually boil with clear liquid that then turns to puss, however this time he got a blood clot in the flat part where finger presses down. Patient was worried because he has heard about issues with blood clots with the vaccine. Patient took two 325mg aspirin after he incurred the injury to his finger. Then took pineapple, bromaline, that is a blood thinner. Therapeutic measures were taken as a result of event. The outcome of the event was unknown.   No follow-up attempts are possible, Information about lot/batch number cannot be obtained.
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: Herpes zoster
Clinical narrative: I developed shingles 3 weeks after the 2nd dose; This is a spontaneous report from a contactable Consumer (patient himself). A 63-years-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection, Batch/Lot Number: EN 8733), dose 2 via an unspecified route of administration, administered in Arm Right on 06Apr2021 at 15:00 (at the age of 63-years-old) as a DOSE 2, SINGLE for covid-19 immunisation. The patient medical history included hypothyroidism, barrett's oesophagus, osteoarthritis, depression, cardiovascular disorder, seasonal affective disorder and hypertension all from an unknown date and unknown if ongoing. The patient previously took wellbutrin and experienced hypersensitivity and received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection, Batch/Lot Number: EN 6208), dose 1 via an unspecified route of administration, administered in Arm Right on 16Mar2021 at 01:15 PM, (at the age of 63-years-old) as a DOSE 1, SINGLE for covid-19 immunisation. Patient did not receive other vaccine in four weeks. Other medications in two weeks reported as, too many to list (unspecified). The patient did not have covid prior vaccination and was not tested for covid post vaccination. The patient said, I developed shingles 3 weeks after the 2nd dose on 03May2021. Event treatment included medication (unspecified). Outcome of the event was not recovered.  No follow-up attempts are possible. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Herpes zoster
Clinical narrative: shingles; This is a spontaneous report from a contactable consumer. A female patient (reporter's mother) of unspecified age received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection; Lot number: unknown) via an unspecified route of administration as single dose for COVID-19 immunization. Medical history, concomitant conditions or past drug history of the patient were not reported. On an unspecified date within days after receiving first dose of vaccination patient experienced shingles. Patient now fear to get the second dose. Outcome of the event was unknown.  No Follow-up attempts are possible. Information about Lot/Batch number cannot be obtained. No further information is expected.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: rash in buttlocks; This is a spontaneous report from a contactable consumer (patient). A 75-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 2 via an unspecified route of administration, administered in Arm Left on 19Feb2021 02:30 (Batch/Lot Number: EN6201) as dose 2, single (at the age of 75 years) for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient received the first dose of BNT162B2 on 29Jan021 (lot:EL9263) given in the left arm for Covid-19 immunization and experienced extreme fatigue for 5 days, inflammation, swollen lymph node upon tongue, painful under tongue. The patient experienced rash in buttlocks on an unspecified date with outcome of unknown.  No follow-up attempts are needed. No further information is expected. Information about batch/lot number already obtained.
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Anxiety, Confusional state, Restlessness, SARS-CoV-2 test, Tachycardia
Clinical narrative: tachycardia; anxiety; restlessness; confusion; This is a spontaneous report from a contactable consumer or other non hcp. A 38-years-old non-pregnant female patient received bnt162b2 (BNT162B2; solution for injection;Lot number ep7534 expiry date was not reported), dose 1 via an unspecified route of administration at arm left on 20Mar2021 (at the age of 38-years-old) as a single dose for covid-19 immunisation. The patient medical history and concomitant medications were not reported. Prior to the vaccination the patient was not diagnosed with COVID-19. Since the vaccination the patient had not been tested for COVID-19. Patient did not had allergies. Patient dose 2 (Lot number EW0153 expiry date was not reported) via an unspecified route of administration at arm left on 20Mar2021 as a single dose for covid-19 immunisation, On 11Apr2021 tachycardia, anxiety, restlessness, confusion. The patient underwent lab tests and procedures which included sars-cov-2 test negative on 25Apr2021. Therapeutic measures were taken as a result of tachycardia, anxiety, restlessness, confusion. Outcome of the events were recovering.   No follow up attempts are possible. No further information is expected
Sex: F
Vaccine: COVID19
Symptoms: Herpes zoster, Tinnitus
Clinical narrative: Shingle-like response; Tinnitus; This is a spontaneous report received from a contactable consumer. This consumer (patient) reported for herself.  A female patient of unspecified age received a dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot Number: ER8733, Expiration date: unknown), via unspecified route, administered in left arm on 26Mar2021 15:30 as dose 1, single for COVID-19 immunization. The patient medical history includes Seasonal allergy and Colitis ulcerative both from an unknown onset and ongoing and concomitant medications includes Fluticasone Propionate and Cetirizine Hydrochloride (ZYRTEC ALLERGY). On 26Mar2021, after the vaccination, the patient experienced reported tinnitus and shingle-like response after being administered that first dose of Pfizer Covid Shot. She already reported this to the  VAERS site or whatever but has not reported this to Pfizer previously. She is still experiencing this. Described as a ringing in her ear non-stop. She is assuming it is Meniere's disease; but it is a buzz in her head. It is hard to distinguish whether it is in her head or ears, but she thinks it is probably ears. It was sudden onset particularly when they gave her the Pfizer Covid Shot. She went to sit in that area that they wait in it was severe at that time worse at that time, but it is still ongoing. She does not plan to get the second dose of the Pfizer Covid Shot due to this event. She wanted to get the shot for shingles, but she had to wait. She mentioned that the Pfizer Covid Shot produced a shingle-like response in her system like a shingles rash that lasted like a week which terrified her. She still needs to get the shingles shots. She can't say 100% that event was shingles, but it looked very close to shingles; the rash itched and burned like nothing she has ever felt in her life. According to her brother who had shingles that's what his shingles felt like when he had shingles. Shingle-like response started probably like a week and a half after she was administered Pfizer Covid Shot. No other vaccines were taken four weeks Prior to vaccination. The outcome of the event tinnitus was recovering and herpes zoster was unknown.  No follow-up attempts possible. No further information expected.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Herpes zoster
Clinical narrative: I have a confirmed case of mild shingles rash on chest.; This is a spontaneous report from a contactable consumer (patient). A 43-year-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number: ECO0170), via an unspecified route of administration, administered in Arm Left on 29Apr2021 10:45 (at the age of 43-year-old) as dose 2, single for covid-19 immunisation. Medical history included allergy to Sulfa- mild rash. There were no concomitant medications. The patient previously received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/Lot Number: CP7533), administered in Arm Left on 08Apr2021 10:30 (at the age of 43-year-old) as dose 1, single for covid-19 immunisation. Patient did not receive any other vaccine in four weeks and did not receive any other medications in two weeks. The patient reported she had a confirmed case of mild shingles rash on chest on 03May2021 13:00. Patient did not have COVID prior vaccination and COVID was not tested post vaccination. AE resulted in doctor or other healthcare professional office/clinic visit. Patient received treatment for adverse event that included Antiviral medicine and ointment. The outcome of event was not recovered.  No follow up attempts are possible. No further information is expected.